Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial.
Journal Information
Full Title: BMC Endocr Disord
Abbreviation: BMC Endocr Disord
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Competing interestsThe authors declare no competing interests. Ethics approval and consent to participateThis study has been approved by the Medical Ethics Committee of the Jiangsu Hospital of Integrated Traditional Chinese and Western Medicine (2021-LWKYZ-002) according to the Medical Research Involving Human Subjects Act and the standards of Good Clinical Practice. Written informed consent will be obtained from all participants prior to study participation. Consent to publishNot applicable. Competing interests The authors declare no competing interests."
"Funding The 16th batch of “Six Talent Peak” projects in Jiangsu Province of China (WSN-035)."
"Trial registration ChiCTR2100043770(February 28, 2021)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025